Recent advances in developing polymeric micelles for treating cancer: Breakthroughs and bottlenecks in their clinical translation
- PMID: 35158056
- DOI: 10.1016/j.drudis.2022.02.005
Recent advances in developing polymeric micelles for treating cancer: Breakthroughs and bottlenecks in their clinical translation (V体育ios版)
"V体育2025版" Abstract
Polymeric micelles (PMs) have been explored pre-clinically for the delivery of chemotherapeutics to treat cancer. Their unique features, such as easy surface functionalization, stimuli-responsiveness, good stability, ability to modify drug release, enhanced permeation and retention effect, and potential to encapsulate more than one type of therapeutic molecules at a time, make them unique carriers for the targeted delivery or for enhancing the bioavailability of chemotherapeutics. PMs can also be used as theranostic nanocarriers for the mapping of drug therapy along with tumor imaging in patients with cancer. This review focuses on the limitations of existing treatment strategies and on innovative approaches employed for the functionalization of PMs for targeting cancer cells VSports手机版. In addition, the bottlenecks associated with the translation of PMs from the laboratory to clinics are also discussed. .
Keywords: Cancer; Clinical applications; Polymeric micelles; Site-specificity; Theranostic. V体育安卓版.
Copyright © 2022 Elsevier Ltd. All rights reserved V体育ios版. .
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Publication types
"V体育ios版" MeSH terms
- Actions (V体育平台登录)
- Actions (VSports手机版)
- V体育平台登录 - Actions
- V体育2025版 - Actions
- VSports最新版本 - Actions
- Actions (V体育2025版)
VSports app下载 - Substances
- "V体育官网" Actions
VSports手机版 - LinkOut - more resources
Full Text Sources
Medical